Article
Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.
Journal of pediatric endocrinology & metabolism : JPEM - 26 Jan 2018
Korula Sophy, Chapla Aaron, Priyambada Leena, Mathai Sarah, Simon Anna
Abstract excerpt
BACKGROUND: Congenital hyperinsulinism results in refractory hypoglycemia. If a therapy with diazoxide has been unresponsive this has been treated by subtotal pancreatectomy in the past. This therapeutic option poses an increased risk of developing diabetes at a later stage. There have been a few case reports on the use of sirolimus in such situations in the recent past. CASE PRESENTATION: Our patient was started...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
